Skip to main content

TYVASO DPI IS NOW APPROVED

Learn more

FOR US HEALTHCARE PROFESSIONALS ONLY

For the treatment of pulmonary arterial hypertension (PAH) (WHO Group 1) to improve exercise ability.

FOR US HEALTHCARE PROFESSIONALS ONLY

SELECT INDICATION
Request a Rep

Request a Rep

Thank you for your interest in TYVASO. We’re here to help.

To have a United Therapeutics Cardiopulmonary Specialist contact you about TYVASO for PAH, please fill out the form below and click Submit.

*Required Field

YOU ARE NOW LEAVING THE TYVASOHCP.COM WEBSITE

This link will take you to a site maintained by a third party who is solely responsible for the site’s content. Click CONTINUE to proceed or CLOSE to return to www.TYVASOhcp.com/pah.

CONTINUE

Privacy

United Therapeutics respects your right to have your personal information kept private. We may use this information to send you materials on our products and services that may be of interest to you. We will not share your information with any third parties or outside mailing lists.

Clicking the Submit button signifies that you have read and agree to our Privacy Policy, and that you agree to receive future communications from TYVASOhcp.com or United Therapeutics Corporation.

Thank You

Your request has been submitted. A Cardiopulmonary Specialist will contact you shortly.